Davita Inc.
Davita
DVA · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $13.6B
- Assets
- $17.5B
- SEC filing
- DEF 14A
- Filed
- April 22, 2026
Executive Compensation
Compensation reported for Davita’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Javier J. Rodriguez
Chief Executive Officer
$18.2M
Reported total
- Salary
- $1,500,000
- Stock awards
- $11,442,481
- Incentives
- $2,089,491
- Option awards
- $2,699,982
- Other
- $478,643
Joel Ackerman
Chief Financial Officer And Treasurer
$6.1M
Reported total
- Salary
- $834,616
- Stock awards
- $3,644,589
- Incentives
- $774,063
- Option awards
- $860,008
- Other
- $16,686
David P. Maughan
Chief Operating Officer, Da Vita Kidney Care
$5.6M
Reported total
- Salary
- $725,000
- Stock awards
- $3,178,454
- Incentives
- $686,330
- Option awards
- $750,001
- Other
- $252,474
Kathleen A. Waters
Chief Legal And Public Affairs Officer
$3.9M
Reported total
- Salary
- $750,000
- Stock awards
- $2,034,334
- Incentives
- $662,664
- Option awards
- $479,982
- Other
- $16,665
James O. Hearty
Chief Compliance Officer
$2M
Reported total
- Salary
- $600,000
- Stock awards
- $720,420
- Incentives
- $455,331
- Option awards
- $170,012
- Other
- $16,352
Javier J. Rodriguez
Chief Executive Officer
$18.2M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 22, 2026.
- Salary
- $1.5M
- Stock Awards
- $11.4M
- Option Awards
- $2.7M
- Incentives
- $2.1M
- Other
- $479K
Historical Compensation
Javier J. Rodriguez total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,500,000 | $11,442,481 | $18,210,597 |
| 2024 | $1,500,000 | $15,849,833 | $21,807,489 |
| 2023 | $1,407,692 | $0 | $6,712,328 |
Named Executive Officers
Javier J. Rodriguez
Chief Executive Officer
Davita · DVA
$18.2M
FY 2025 · DEF 14A
Joel Ackerman
Chief Financial Officer And Treasurer
Davita · DVA
$6.1M
FY 2025 · DEF 14A
David P. Maughan
Chief Operating Officer, Da Vita Kidney Care
Davita · DVA
$5.6M
FY 2025 · DEF 14A
Kathleen A. Waters
Chief Legal And Public Affairs Officer
Davita · DVA
$3.9M
FY 2025 · DEF 14A
James O. Hearty
Chief Compliance Officer
Davita · DVA
$2M
FY 2025 · DEF 14A
Source information
- Company
- Davita Inc.
- Ticker
- DVA · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 22, 2026
- SEC accession number
- 0000927066-26-000053
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →